NEVVI Medicare utilization intelligence

← back

ESTHER, JOHNM.D. NPI 1174056121 Clinician

Hematology-Oncology · SPRINGDALE, AR

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 9 years since medical school (class of 2017, self-reported to CMS)
Location SPRINGDALE, AR · NPPES registered location
Active in data Billed Medicare 2023–2024 (2 consecutive years)
Scale 122 codes billed · 203,387 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20242026
HIGHLANDS ONCOLOGY GROUP PA
2024–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-01

Year: 2024 · 2023

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9299 Injection, nivolumab, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9271 Injection, pembrolizumab, 1 mg
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
A9575 Injection, gadoterate meglumine, 0.1 ml
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1071 Injection, testosterone cypionate, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
J0897 Injection, denosumab, 1 mg
J9267 Injection, paclitaxel, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1437 Injection, ferric derisomaltose, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
J9041 Injection, bortezomib, 0.1 mg
Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1745 Injection, infliximab, excludes biosimilar, 10 mg
80053 Blood test, comprehensive group of blood chemicals
J2469 Injection, palonosetron hcl, 25 mcg
83735 Magnesium level
84550 Uric acid level, blood
83615 Lactate dehydrogenase (enzyme) level
84100 Phosphate level
82248 Bilirubin level, direct
J2919 Injection, methylprednisolone sodium succinate, 5 mg
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
J3480 Injection, potassium chloride, per 2 meq
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
82728 Ferritin (blood protein) level
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J9045 Injection, carboplatin, 50 mg
83540 Iron level
83550 Iron binding capacity
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9060 Injection, cisplatin, powder or solution, 10 mg
J3475 Injection, magnesium sulfate, per 500 mg
84443 Blood test, thyroid stimulating hormone (tsh)
96375 Injection of additional new drug or substance into vein
J3489 Injection, zoledronic acid, 1 mg
A9573 Injection, gadopiclenol, 1 ml
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
71260 Ct scan of chest with contrast
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
J9000 Injection, doxorubicin hydrochloride, 10 mg
84153 Psa (prostate specific antigen) measurement, total
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
74178 Ct scan of abdomen and pelvis before and after contrast
96417 Administration of additional new drug or substance into vein, 1 hour or less
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J3490 Unclassified drugs
96415 Administration of chemotherapy into vein, each additional hour
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
83521 Measurement of immunoglobulin light chains
84439 Thyroxine (thyroid chemical), free
J7030 Infusion, normal saline solution , 1000 cc
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96360 Infusion into a vein for hydration, 31-60 minutes
84436 Thyroxine (thyroid chemical), total
83690 Lipase (fat enzyme) level
82306 Vitamin d-3 level
82150 Amylase (enzyme) level
82784 Gammaglobulin (immune system protein) measurement
36415 Insertion of needle into vein for collection of blood sample
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
86140 Measurement c-reactive protein for detection of infection or inflammation
82977 Glutamyltransferase (liver enzyme) level
A9596 Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
82378 Carcinoembryonic antigen (cea) protein level
82232 Beta-2 microglobulin (protein) level
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
70553 Mri scan of brain before and after contrast
J1940 Injection, furosemide, up to 20 mg
70491 Ct scan of soft tissue of neck with contrast
96411 Administration of additional new drug or substance into vein using push technique
J2250 Injection, midazolam hydrochloride, per 1 mg
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
82565 Blood creatinine level
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
71250 Ct scan of chest without contrast
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
81001 Manual urinalysis test with examination using microscope, automated
96523 Irrigation of implanted venous access drug delivery device
99239 Hospital discharge day management, more than 30 minutes
71046 X-ray of chest, 2 views
78816 Nuclear medicine study whole body with ct scan
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
82533 Cortisol (hormone) measurement, total
81003 Automated urinalysis test
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
99442 Telephone medical discussion with physician, 11-20 minutes
70470 Ct scan of head or brain before and after contrast
85610 Blood test, clotting time
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function
G0008 Administration of influenza virus vaccine
85045 Red blood count, automated test
90653 Influenza vaccine, inactivated
96374 Injection of drug or substance into vein
74176 Ct scan of abdomen and pelvis without contrast
74183 Mri scan of abdomen before and after contrast
80400 Hormonal panel for adrenal gland assessment (adrenal gland insufficiency)
96409 Administration of chemotherapy into vein using push technique
J2175 Injection, meperidine hydrochloride, per 100 mg
96361 Infusion into a vein for hydration, each additional hour
99195 Drawing of blood for a medical problem
99443 Telephone medical discussion with physician, 21-30 minutes
90480 Admn sarscov2 vacc 1 dose
93356 Heart muscle strain imaging
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.